Emerging Technologies Ushering the Life Sciences Industry into the Metaverse, according to Accenture Report – Newsroom | Accenture

Growing Technologies Ushering the Life Sciences Industry into the Metaverse, according to Accenture Report
91% of medical technology and 85% of biopharma executives expect new technologies to have a positive impact on the industry

NEW YORK; Aug. 22, 2022 – Accenture’s (NYSE: ACN) Existence Sciences Technology Vision 2022 report explores the technologies trends that will transform how biopharmaceutical and medical technology companies solve manufacturing and device problems, improve equity in clinical trial participation and build more resilient supply chains to provide patients plus healthcare professionals with a lot more personalized experiences.
The metaverse is an evolving and expanding continuum on multiple dimensions — digital and physical — that will comprises systems including extended reality, blockchain, artificial intelligence, digital twins, non-fungible tokens, and smart devices. According to the report, life sciences leaders (91% associated with medical technology executives and 85% biopharma executives) anticipate the metaverse to have a positive impact upon their organizations and nearly half of the particular biopharma executives surveyed believe the metaverse will have a breakthrough or transformational impact on their organizations.
Petra Jantzer, global industry life sciences lead at Accenture, said, “We are in the early days of the metaverse, plus the technologies innovations we implement today — the particular solutions, products and services companies offer, how they develop and distribute them and how these people fundamentally operate their businesses — are the building blocks of the future for life sciences. Business leaders are usually pioneering a new digital future for how people plus enterprises interact, and many of the rules remain undefined. It is critical that life sciences companies take steps in order to proactively and responsibly shape the metaverse continuum. ”

To help life sciences companies design, execute plus accelerate their own metaverse journeys, Accenture recently launched the particular Accenture Metaverse Continuum business group , which combines metaverse-skilled professionals and market-leading capabilities inside customer experience, digital commerce, extended reality, blockchain, electronic twins, artificial intelligence, and computer vision.
In the report, four technology trends that underpin the metaverse continuum are explored.

  • WebMe illustrates how the internet will be being reimagined with the particular metaverse as a platform for digital experiences that provide boundless places where people can meet and socialize, and Web3 is reinventing how data can be owned by individuals plus moved with the person and not the platform. In the future, a brand new generation of electronic devices will integrate in to the metaverse and could include smart technology in everyday objects like home appliances, and ‘smart’ cars that provide salient information on healthy human behaviors along with medically regulated devices such as Donisi, which can simultaneously detect plus analyze multiple bio-parameters.
  • The Programmable World tracks how technology is being threaded through our physical environments in three layers: connected, experiential, and material. Nearly nine-in-10 of the MedTech and biopharma executives surveyed believe that will programming the physical environment will emerge as a competitive differentiation within their business. Augmented fact, 5G, ambient computing, 3D printing, plus smart materials are converging in sophisticated ways, turning the bodily world directly into an atmosphere that is because smart, customizable, and as programmable as the digital one.
  • The Unreal explores the particular “unreal” qualities that are becoming fundamental to artificial cleverness (AI), and even data, making the synthetic seem authentic. Synthetic data is being used in order to train AI models in ways that real-world information practically cannot or should not. Synthetic data can represent patient datasets for use in research, training, or even other applications. This realistic (yet unreal) data can be shared, maintaining the same statistical properties while protecting confidentiality plus privacy. It can become developed to accommodate increased diversity in order to counter bias, thus overcoming the pitfalls of real-world data. More than nine-tenths associated with biopharma (92%) and MedTech (91%) professionals report that will their organization is dependent on AI technologies to function effectively.
  • Computing the Impossible  is the emergence of a new class of machines  —  quantum computing  —  stretching the particular boundaries of what computers can do. Problems once thought impossible to solve because they require computing large, complex datasets are now in the realm from the possible. Nearly all the surveyed biopharma (94%) and MedTech (96%) executives agree that their particular organization is pivoting within response in order to the unprecedented computational power which is getting available.

The particular Life Sciences Technology Vision 2022 report can be accessed here .
About the Methodology
For the particular 2022 statement, the research process included gathering input from the Technologies Vision External Advisory Board, a group comprising more than two dozen experienced individuals from the public plus private sectors, academia, venture capital firms, and entrepreneurial businesses. In addition, the Technology Vision team conducted interviews with technology luminaries plus industry experts, as well since many Accenture business frontrunners. In parallel, Accenture Research conducted the global survey of 24, 000 consumers and 4, 650 C-level executives and directors across 35 countries and 23 industries. The biopharmaceutical market sample comprised 100 executives in eight countries (China, France, Germany, India, Japan, Switzerland, the United Kingdom and the United States). Surveys were fielded in April 2022. The medical technology sector sample made up 100 business owners in 8 countries (China, France, Philippines, India, The japanese, Switzerland, the particular United Kingdom and the United States). Surveys were fielded in April 2022.
Regarding Accenture
Accenture is a global professional services company along with leading capabilities in electronic, cloud, plus security. Combining unmatched experience and specialized skills throughout more than 40 industries, all of us offer Strategy and Consulting, Technology and Operations solutions, and Accenture Song — all powered by the world’s largest network associated with Advanced Technology plus Intelligent Operations centers. Our 710, 000 people deliver on the promise of technologies and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners, plus communities. Visit us at  accenture. com .

# # #

Marchell Gillis
+1. 678. 657. 7515
marchell. [email protected] com
Copyright © 2022 Accenture. All rights reserved. Accenture and its logo are usually trademarks of Accenture.   This content is provided for general information purposes and is not really intended to end up being used in place of consultation with our professional advisors. This document refers to marks owned by third parties. Almost all such third-party marks are the property of their respective owners. No sponsorship, endorsement or approval associated with this content by the particular owners of such marks is intended, expressed or implied.